PackTalk is a blog for the Healthcare Packaging Industry

Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test


Published on June 4, 2020

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. 

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.


Comments (0)

Related Articles

Wishes for the Chinese Lunar New Year of the Ox

February 26, 2021

Our team in China, along with many people around globejust celebrated the 2021 Spring Festival and entered the Lunar New Year, the Year of Ox. Ox is one of China’s Zodiac and in Chinese culture the ois a hard-working and docile animal. Isymbolizes...

Learn More

Opportunities in Optimizing Pouch Design

February 26, 2021

What comes to mind if I ask you to think of a medical sterile barrier pouch? Whether you’re new to or experienced in healthcare packaging, I bet a chevron seal is the image that pops into your head. It is, after all, the go-to design across the industry, for...

Learn More

Conversations in the Medical Device Industry

February 26, 2021

“By failing to prepare, you are preparing to fail.” - Benjamin Franklin

Benjamin Franklin was right. We must apply lessons learned to current industry action plans. 

For nearly a year, the majority of published content (professional or leisure) has...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.